| Mrs Karyn Lynette Molinari-fryer, DO | |
|
139 Conference Center Way, Suite 113, Bridgeport, WV 26330 | |
| (304) 599-8000 | |
| (304) 599-8003 |
| Full Name | Mrs Karyn Lynette Molinari-fryer |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Adolescent Medicine |
| Location | 139 Conference Center Way, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669669453 | NPI | - | NPPES |
| 3810010249 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | 2090 (West Virginia) | Primary |
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Boston Scientific Corporation has announced that results of the largest implantable cardioverter defibrillator (ICD) study to date, known as INTRINSIC RV, were published in the January issue of the journal Circulation.
Low levels of vitamin C were associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients, in research presented at the American Heart Association's Scientific Sessions 2011.
Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.
Stroke is the leading cause of disability in older adults in the United States, but research by Clarkson University Associate Professor of Physical Therapy George Fulk and his colleagues is pointing the way to recovery for people who are relearning how to walk.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Karyn Lynette Molinari-fryer, DO 1247 Suncrest Town Center, Morgantown, WV 26505 Ph: (304) 599-8000 | Mrs Karyn Lynette Molinari-fryer, DO 139 Conference Center Way, Suite 113, Bridgeport, WV 26330 Ph: (304) 599-8000 |
News Archive
Boston Scientific Corporation has announced that results of the largest implantable cardioverter defibrillator (ICD) study to date, known as INTRINSIC RV, were published in the January issue of the journal Circulation.
Low levels of vitamin C were associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients, in research presented at the American Heart Association's Scientific Sessions 2011.
Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.
Stroke is the leading cause of disability in older adults in the United States, but research by Clarkson University Associate Professor of Physical Therapy George Fulk and his colleagues is pointing the way to recovery for people who are relearning how to walk.
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months via injection.
› Verified 4 days ago
Jennifer Jill Momen, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 11 Chenoweth Drive, Suite A, Bridgeport, WV 26330 Phone: 303-842-5777 Fax: 304-842-3318 | |
Joseph Momen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7 Chenoweth Dr, Suite A, Bridgeport, WV 26330 Phone: 304-842-5777 Fax: 304-842-3318 | |
Dr. Kristen Nicole Moore, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 710 Genesis Blvd, Bridgeport, WV 26330 Phone: 304-808-6065 Fax: 304-808-6067 | |
Brian Christopher Policano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 7 Chenoweth Dr, Suite A, Bridgeport, WV 26330 Phone: 304-842-5777 Fax: 304-842-3318 | |
Dr. Bradley D. Mitchell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 139 Conference Center Way Ste 113, Bridgeport, WV 26330 Phone: 304-599-8000 Fax: 304-599-8003 | |
Dr. Janet E. Cogar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 900 Lodgeville Rd, Bridgeport, WV 26330 Phone: 304-842-3311 Fax: 304-842-3313 |